Arnaud Deladeriere

Director of Process Development • Triumvira Immunologics

Arnaud is the Director of Process Development at Triumvira. He’s responsible for the MSAT group, ranging from Process Development and Automation, for both Autologous and Allogeneic products, as well as the analytical needs for our clinical trials and external manufacturing. Prior to Triumvira, he was working at a CGT CDMO called C3i Center, based in Montreal. There he was managing the operations of the GMP MFG unit where most projects were CAR and TCR based products (with the occasional stem cell or TIL project). He has a scientific background, with a PhD in Cell and Molecular Biology from the University of Cambridge in the UK.

Also Speaking

Nina Bauer

Global Head of Commercial, Biologics and Viral Vector CTDMO • MilliporeSigma

Robert Keefe

Chief Development Officer • BlueSphere Bio

Steven B. Miller

Event Info


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.